MLAB
MESA LABORATORIES INC /CO/
+2.96 (+2.36%)128.25USD30.0K成交股數718M市值150.9本益比(近四季)2.9股價營收比+1.0%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 60.1M+1% | 63.7M+1% | 65.1M+13% | 60.7M+4% | 59.5M+1% | 62.8M+18% | 57.8M+9% | 58.2M+15% | 58.9M | 53.5M | 53.2M | 50.6M |
| 營業成本 | 21.1M | 21.5M | 23.3M | 23.4M | 22.6M | 23.1M | 22.4M | 20.9M | 22.3M | 20.1M | 21.1M | 19.5M |
| 毛利 | 39.0M+6% | 42.2M+6% | 41.8M+18% | 37.3M+0% | 36.9M+1% | 39.8M+19% | 35.5M+10% | 37.2M+19% | 36.6M | 33.4M | 32.1M | 31.2M |
| 毛利率 | 64.9% | 66.2% | 64.2% | 61.5% | 62.0% | 63.3% | 61.3% | 64.0% | 62.1% | 62.5% | 60.4% | 61.6% |
| 研發費用 | 4.7M | 5.2M | 5.0M | 5.0M | 5.0M | 5.1M | 4.6M | 4.7M | 5.2M | 4.3M | 5.0M | 4.8M |
| 銷售管理費用 | 17.4M | 24.1M | 18.8M | 17.8M | 18.0M | 18.5M | 17.5M | 16.8M | 17.8M | 19.4M | 17.5M | 18.1M |
| 營業利益 | 7.0M+129% | 2.7M-52% | 8.0M+127% | 4.7M-15% | 3.1M-101% | 5.8M-8725% | 3.5M-5947% | 5.6M-940% | −271M | −67K | −60K | −664K |
| 營業利益率 | 11.7% | 4.3% | 12.2% | 7.8% | 5.1% | 9.2% | 6.1% | 9.6% | -460.6% | -0.1% | -0.1% | -1.3% |
| 稅後淨利 | 2.8M-40% | −4.1M+147% | 3.6M+6% | 2.5M-27% | 4.7M-102% | −1.7M-179% | 3.4M-379% | 3.4M-717% | −255M | 2.1M | −1.2M | −549K |
| 淨利率 | 4.7% | -6.5% | 5.6% | 4.1% | 8.0% | -2.7% | 5.9% | 5.8% | -432.2% | 4.0% | -2.3% | -1.1% |
| 稀釋 EPS | 0.49-42% | -0.74+139% | 0.65+3% | 0.45-27% | 0.85-102% | -0.31-179% | 0.63-374% | 0.62-720% | -47.26 | 0.39 | -0.23 | -0.10 |
| 稀釋股數 | 5.8M | 5.6M | 5.6M | 5.5M | 5.6M | 5.4M | 5.5M | 5.4M | 5.4M | 5.4M | 5.4M | 5.4M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 30.7M | 26.9M | 29.0M | 20.4M | 21.3M | 27.3M | 24.3M | 28.5M | 28.2M | 28.2M | 35.6M | 32.4M |
| 應收帳款 | 34.4M | 44.1M | 40.2M | 40.1M | 39.1M | 42.0M | 40.2M | 35.6M | 39.1M | 36.0M | 36.3M | 35.6M |
| 存貨 | 27.2M | 26.4M | 26.6M | 27.7M | 28.1M | 25.4M | 29.7M | 31.8M | 32.7M | 36.0M | 32.9M | 35.6M |
| 總資產 | 419M | 428M | 435M | 430M | 436M | 433M | 454M | 440M | 447M | 742M | 637M | 643M |
| 有息負債 | 66.1M | 67.5M | 68.4M | 69.4M | 70.3M | 72.2M | 73.1M | 74.1M | – | – | – | – |
| 總負債 | 230M | 242M | 248M | 252M | 263M | 274M | 293M | 290M | 301M | 339M | 249M | 255M |
| 股東權益 | 189M | 186M | 187M | 178M | 172M | 155M | 161M | 151M | 145M | 403M | 388M | 388M |
| 負債比 | 55.0% | 56.5% | 57.1% | 58.5% | 60.4% | 63.1% | 64.4% | 65.8% | 67.5% | 45.7% | 39.1% | 39.7% |
| 淨現金(現金 − 有息負債) | −35.4M | −40.6M | −39.5M | −49.0M | −49.0M | −44.9M | −48.8M | −45.6M | – | – | – | – |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | 14.7M+678% | – | – | – | 1.9M | – | – | 10.7M+8% | – | – | – | 9.9M |
| 資本支出 | 559K | – | – | – | 1.0M | – | – | 891K | – | – | – | 270K |
| 自由現金流 | 14.2M+1504% | – | – | – | 884K | – | – | 9.9M+2% | – | – | – | 9.7M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | 8.1M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | 884K | – | – | – | 873K | – | – | 863K | – | – | – | 859K |
| 自由現金流率 | 23.6% | – | – | – | 1.5% | – | – | 16.9% | – | – | – | 19.1% |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 148M
| Calibration Solutions | 53.6M | 36.3% | +3.5% |
|---|---|---|---|
| Biopharmaceutical Development | 48.6M | 33.0% | -0.2% |
| Clinical Genomics | 45.4M | 30.8% | -3.6% |
| Sterilization And Disinfection Control 小計 | 102M | 68.8% | +8.7% |
地區2026 年度 · 249M
| 美國 | 117M | 46.9% | +0.2% |
|---|---|---|---|
| 其他 | 112M | 44.9% | +12.9% |
| 中國 | 20.4M | 8.2% | -19.2% |
產品／服務2026 年度 · 249M
| 產品 | 203M | 81.6% | +2.5% |
|---|---|---|---|
| 服務 | 45.7M | 18.4% | +7.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 249M | +3.4% | 6.7M | 2.7% | 1.21 | 39.6M |
| FY2025 | 241M | +11.5% | −2.0M | -0.8% | -0.36 | 42.6M |
| FY2024 | 216M | -1.3% | −254M | -117.6% | -47.20 | 41.6M |
| FY2023 | 219M | +18.8% | 930K | 0.4% | 0.17 | 23.4M |
| FY2022 | 184M | +37.6% | 1.9M | 1.0% | 0.35 | 34.8M |
| FY2021 | 134M | +13.8% | 3.3M | 2.4% | 0.64 | 35.1M |
| FY2020 | 118M | +14.1% | 1.8M | 1.5% | 0.41 | 25.5M |
| FY2019 | 103M | – | 7.5M | 7.3% | 1.86 | 29.3M |